![Mary Harler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mary Harler
Keine laufenden Positionen mehr
Profil
Mary Beth Harler formerly worked at IGM Biosciences, Inc., as Chief Executive Officer & Director from 2024 to 2025 and Bristol Myers Squibb Co., as SVP, Head-Immunology & Fibrosis Development.
Dr. Harler received her doctorate degree from Marshall University and undergraduate degree from Wheeling University.
Ehemalige bekannte Positionen von Mary Harler
| Unternehmen | Position | Ende |
|---|---|---|
| IGM BIOSCIENCES, INC. | Vorstandsvorsitzender | 14.08.2025 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Ausbildung von Mary Harler
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
20
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Marshall University
 Marshall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IGM Biosciences, Inc.
 IGM Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops engineered IgM antibodies for the treatment of cancer patients | Health Technology |
